{
  "ticker": "ENL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02974580",
  "id": "02974580",
  "pages": 11,
  "price_sensitive": true,
  "date": "20250730",
  "time": "1514",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250730/pdf/06mb1jf0t02dt1.pdf",
  "summary": "### **Material Information Summary (Enlitic, Inc. \u2013 Quarterly Report & Appendix 4C, Q2 FY25)**  \n\n#### **Financial & Operational Highlights**  \n- **Revenue**: US$1.08m (up 47.9% QoQ).  \n- **Client Growth**: 26 new agreements signed (Q1 FY25: 10), with total contract value of **A$2.3m** (75% to be recognized in 2025).  \n- **Strategic Partnership**: Binding MOU with **GE HealthCare** for **A$50m revenue opportunity** over 5 years (US$2m advance payment received post-quarter).  \n- **Capital Raising**: **A$10m (US$6.4m)** equity raise completed in June 2025 (placement at A$0.04/share).  \n- **Cost Savings**: Reduced net operating cash outflow to **US$3.3m** (from US$3.9m in Q1 FY25); annualized savings of **US$3\u20133.5m** post-Laitek acquisition.  \n- **Cash Position**: **US$5.6m** at quarter-end (up from US$2.78m in Q1 FY25).  \n- **Guidance**: Reiterated target to reach **operational cashflow break-even by end-2025**.  \n\n#### **Key Timelines/Capital Structure**  \n- **Equity Raise**: Completed mid-June 2025 (250m shares issued at A$0.04, plus 125m options at A$0.05).  \n- **GE HealthCare Payment**: US$2m received in July 2025 under MOU terms.  \n\n#### **Liquidity Outlook**  \n- **Funding Runway**: 1.69 quarters based on current burn (post-US$2m GE payment extends runway).  \n\n**Omitted**: Routine cost breakdowns, director remuneration, forward-looking disclaimers.",
  "usage": {
    "prompt_tokens": 6018,
    "completion_tokens": 412,
    "total_tokens": 6430,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-30T06:00:39.573726"
}